NSD2 E1099K Drives Relapse in Pediatric Acute Lymphoblastic Leukemia by Disrupting 3D Chromatin Organization

Request Access

The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context–Dependent Manner in Pediatric Acute Lymphoblastic Leukemia

Joanna Pierro, J. Saliba, Sonali Narang, et al.. (2020). Molecular Cancer Research. Cited 22 times. https://doi.org/10.1158/1541-7786.MCR-20-0092
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747